HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlo G Tocchetti Selected Research

Fatty Acids (Saturated Fatty Acids)

10/2015Impaired mitochondrial energy supply coupled to increased H2O2 emission under energy/redox stress leads to myocardial dysfunction during Type I diabetes.
6/2015Protective mechanisms of mitochondria and heart function in diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlo G Tocchetti Research Topics

Disease

28Cardiotoxicity
06/2021 - 02/2012
26Heart Failure
01/2023 - 01/2005
24Neoplasms (Cancer)
01/2022 - 02/2012
8Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2005
7Left Ventricular Dysfunction
01/2022 - 12/2011
5Myocarditis (Carditis)
01/2021 - 01/2019
5Cardiomyopathies (Cardiomyopathy)
01/2020 - 02/2012
4Hypertension (High Blood Pressure)
01/2022 - 01/2015
4Hypertrophy
01/2022 - 05/2008
4Fibrosis (Cirrhosis)
01/2020 - 05/2008
3Inflammation (Inflammations)
01/2022 - 05/2016
3Heart Block
11/2020 - 01/2019
3Cardiogenic Shock
11/2020 - 01/2019
3Myocardial Ischemia (Ischemic Heart Diseases)
05/2016 - 01/2015
2Reperfusion Injury
02/2022 - 02/2007
2Infarction (Infarctions)
02/2022 - 01/2015
2Heart Arrest (Cardiac Arrest)
01/2020 - 01/2019
2Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2018 - 01/2018
2Cardiomegaly (Heart Hypertrophy)
01/2018 - 05/2008
2Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 01/2018
2Mitochondrial Diseases (Mitochondrial Disease)
06/2016 - 06/2015
2Leukemia
05/2016 - 05/2016
2Thrombosis (Thrombus)
05/2016 - 05/2016
2Cardiac Arrhythmias (Arrythmia)
09/2014 - 04/2013
1Ischemia
02/2022
1Cystic Fibrosis (Mucoviscidosis)
01/2022
1Ectopic Atrial Tachycardia
01/2022
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2022
1Asthma (Bronchial Asthma)
01/2022
1Hodgkin Disease (Hodgkin's Disease)
01/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2022
1Frailty
11/2021
1COVID-19
11/2021
1Multiple Myeloma
11/2020
1Death (Near-Death Experience)
11/2020

Drug/Important Bio-Agent (IBA)

13AnthracyclinesIBA
11/2020 - 02/2012
10Immune Checkpoint InhibitorsIBA
06/2021 - 11/2017
8Antineoplastic Agents (Antineoplastics)IBA
12/2018 - 06/2012
7Biomarkers (Surrogate Marker)IBA
10/2022 - 05/2016
6Trastuzumab (Herceptin)FDA Link
11/2020 - 12/2011
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 06/2012
5nitroxylIBA
02/2022 - 12/2005
4omega-Chloroacetophenone (Mace)IBA
01/2021 - 01/2019
4Glucose (Dextrose)FDA LinkGeneric
01/2020 - 04/2013
3Proteasome InhibitorsIBA
11/2020 - 05/2016
3Phosphotransferases (Kinase)IBA
11/2020 - 03/2016
3TroponinIBA
01/2019 - 05/2016
3Natriuretic PeptidesIBA
01/2018 - 05/2016
2Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2022 - 02/2007
2Vasodilator Agents (Vasodilators)IBA
01/2021 - 05/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020 - 06/2016
2Adrenergic Agents (Adrenergic Drugs)IBA
01/2020 - 03/2016
2PalmitatesIBA
01/2020 - 10/2015
2CalciumIBA
01/2018 - 01/2016
2RanolazineFDA Link
01/2018 - 04/2014
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2018 - 04/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 04/2014
2ErbB Receptors (EGF Receptor)IBA
05/2016 - 05/2016
2Growth Factor ReceptorsIBA
05/2016 - 05/2016
2Free RadicalsIBA
05/2016 - 05/2016
2Angiogenesis InhibitorsIBA
05/2016 - 05/2016
2Oxygen (Dioxygen)IBA
01/2016 - 05/2014
2Fatty Acids (Saturated Fatty Acids)IBA
10/2015 - 06/2015
2Insulin (Novolin)FDA Link
10/2015 - 04/2013
2AntioxidantsIBA
04/2013 - 05/2008
2oxyhyponitriteIBA
12/2005 - 01/2005
1KATP ChannelsIBA
02/2022
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2022
1Tetrazolium SaltsIBA
02/2022
1liposomal doxorubicin (Doxil)FDA Link
01/2022
1Adenosine (Adenocard)FDA LinkGeneric
01/2022
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2022
1Mitochondrial Form Creatine KinaseIBA
01/2022
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1Ion Channels (Ion Channel)IBA
01/2022
1Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2022
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2022
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
01/2022
1atezolizumabIBA
06/2021
1avelumabIBA
06/2021
1durvalumabIBA
06/2021
1cemiplimabIBA
06/2021
1pembrolizumabIBA
06/2021
1IpilimumabIBA
06/2021
1NivolumabIBA
06/2021
1Monoclonal AntibodiesIBA
06/2021
1AndrogensIBA
11/2020
1Immunomodulating AgentsIBA
11/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2020

Therapy/Procedure

26Therapeutics
01/2023 - 05/2014
8Drug Therapy (Chemotherapy)
01/2022 - 06/2012
3Immunotherapy
06/2021 - 01/2018
3Aftercare (After-Treatment)
12/2019 - 06/2016
2Transplantation
01/2022 - 01/2018
2Secondary Prevention
05/2016 - 05/2016
1Hand Hygiene
11/2021
1Heart Transplantation (Grafting, Heart)
11/2021